Shorten the drug patent times and let the generics compete with lower prices.
"Is our totally wrongfully made President President very sick? Why else would he make medication cheap, which, according to our analysts, benefits only the 'poor' and 'sick'."
An example : product name …Fesofor
: ingredient…..ferrous sulphate
: chemical name ….FeSO4
@GottaLaff
My mother takes Eliquis. It's EXPENSIVE!
Maybe now the drug companies won't have as much money to put on annoying commercials.
The following drugs are subject to Medicare price negotiations and are used to treat the following conditions[1][2][3][4][5][6]: - Eliquis: a blood thinner used to prevent blood clots. - Jardiance: a diabetes drug used to lower blood sugar levels. - Xarelto: a blood thinner used to prevent blood clots. - Januvia: a diabetes drug used to lower blood sugar levels. - Farxiga: a diabetes drug used to lower blood sugar levels. - Entresto: a heart failure drug used to treat heart failure. - Enbrel: a drug used to treat rheumatoid arthritis and other autoimmune diseases. - Imbruvica: a leukemia drug used to treat certain types of leukemia. - Stelara: a drug used to treat psoriasis and Crohn's disease. - Fiasp: a diabetes drug used to lower blood sugar levels. These drugs accounted for $50.5 billion, or about 20%, in total Part D gross covered prescription drug costs, between June 1, 2022, and May 31, 2023[5].
Fiasp - insulin shot
Stelara - Crohns, IBS etc
Imbruvica - cancer in kids
Enbrel - rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis
Entresto - heart failure, blood pressure
Farxiga - diabetes
Januvia - diabetes
Xarelto - high blood pressure
Jardiance - lowers blood sugar-diabetes
Eliquis - stops blood clots from forming due to a certain irregular heartbeat